Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Anticancer Research|November 2, 2010
Clinicopathological significance of p53, hypoxia-inducible factor 1alpha, and vascular endothelial growth factor expression in colorectal cancerHyuk-Chan Kwon, Sung Hyun Kim, Sung Yong Oh, et al.
The Korean Journal of Hematology|December 2, 2010
Fludarabine-based myeloablative regimen as pretransplant conditioning therapy in adult acute leukemia/myelodysplastic syndrome: comparison with oral or intravenous busulfan with cyclophosphamideJi Hyun Lee, Jimin Choi, Kyung A Kwon, et al.
Cancer Research and Treatment|September 12, 2009
Extraskeletal mesenchymal chondrosarcoma of the heart responded to systemic chemotherapy: a case reportChien Ter Hsing, Sung Yong Oh, Suee Lee, et al.
Cancer Research and Treatment|September 12, 2009
A phase II study of paclitaxel and cisplatin as salvage therapy for patients with advanced or metastatic gastric cancerBong-Gun Seo, Sung Yong Oh, Dong Mee Lee, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 21, 2009
Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 casesSung Yong Oh, Sung-Hyun Kim, Hyuk-Chan Kwon, et al.
Acta Haematologica|November 29, 2008
Primary penile diffuse large B cell lymphoma treated by local excision followed by rituximab-containing chemotherapyHa Yeon Kim, Sung Yong Oh, Suee Lee, et al.
Investigational New Drugs|February 4, 2012
A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancerIn Gyu Hwang, Joung-Soon Jang, Sung Yong Oh, et al.
Cancer Research and Treatment|December 27, 2024
Pemetrexed Maintenance versus Observation in Patients with Advanced Urothelial Carcinoma Who Completed First-line Platinum-based Chemotherapy without Disease Progression (PREMIER, KCSG GU16-05)Inkeun Park, Shinkyo Yoon, Ilhwan Kim, et al.
American Journal of Clinical Oncology|April 14, 2009
Second-line treatment with a combination of continuous 5-fluorouracil, doxorubicin, and mitomycin-C (conti-FAM) in gemcitabine-pretreated pancreatic and biliary tract cancerSuee Lee, Sung Yong Oh, Byung Geun Kim, et al.
Cancer Research and Treatment|August 19, 2009
Phase II study of gemcitabine plus cisplatin in patients with anthracycline- and taxane- pretreated metastatic breast cancerJung Hwan Kim, Sung Yong Oh, Hyuk-Chan Kwon, et al.
Pageof 9